drugset / Trial / NCT02400359

Lorcaserin in Obesity: Identification of CNS Targets Using fMRI

NCT02400359

Phase 4 Active not recruiting 40 enrolled Beth Israel Deaconess Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this protocol is to investigate, using functional magnetic resonance imaging (fMRI), the effect of treatment with lorcaserin on centers of the brain that control appetite and food intake, as well as lorcaserin's downstream metabolic effects.

Timeline

Start
2014-10
Primary completion
2027-06
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lorcaserin Small molecule

Indications